Mid-session IV Report December 8, 2023

Mid-session IV Report December 8, 2023

The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By this often over looked information.

Options with increasing option implied volatility: BLUE VKTX LNTH HTZ HOOD WBA HES STZ CAVA MBI MDRX AX PARA BLUE CRSP

Popular stocks with increasing volume: PARA PLTR AI LULU DOCU HOOD BABA RBLX PDD AFRM

Option IV into quarter results

Oracle (ORCL) December call option implied volatility is at 58, January is at 31; compared to its 52-week range of 18 to 47 into the expected release of quarter results after the bell on December 11.

IV Movers

Paramount Global (PARA) 30-day option implied volatility is at 50; compared to its 52-week range of 40 to 68. Call put ratio 4.8 calls to 1 put with focus on December weekly calls as share price up 13%.

bluebird bio (BLUE) December call option implied volatility is at 230, January is at 245; compared to its 52-week range of 64 to 216 into December PDUFA deadline date. Call put ratio 9.5 calls to 1 put.

CRISPR Therapeutics (CRSP) December weekly call option implied volatility is at 370, December is at 121; compared to its 52-week range of 38 to 91 ahead of the December PDUFA. Call put ratio 3 calls to 1 put.

Vertex Pharma (VRTX) 30-day option implied volatility is at 30; compared to its 52-week range of 18 to 32.

MBIA (MBI) 30-day option implied volatility is at 49; compared to its 52-week range of 33 to 106 as share price up 65% amid declaration of special dividend.

Albemarle (ALB) 30-day option implied volatility is at 52; compared to its 52-week range of 31 to 93 as share price up 3.8%.

Options with decreasing option implied volatility: HA REPL GTLB CHWY ASAN DOCU AI MDB DG MANU S RH VEEV LULU CPB VET
Increasing unusual option volume: HCP ALT MJ SMAR AMPY IMPP BITF BLUE CRSP PARA MBI
Active options: AMD TSLA NVDA AMZN AAPL GOOGL GOOG CHPT MARA PLTR META AI LULU DOCU MSFT HOOD BABA RBLX PDD AFRM